Login / Signup

Clinical Outcomes of First Subsequent Therapies After Abiraterone Acetate Plus Prednisone for High-Risk Metastatic Castration-Sensitive Prostate Cancer in the LATITUDE Study.

Yosuke KorokiMasataka Taguri
Published in: Targeted oncology (2022)
ClinicalTrials.gov, NCT01715285, registered 26 October, 2012.
Keyphrases
  • prostate cancer
  • squamous cell carcinoma
  • small cell lung cancer
  • radical prostatectomy